Key result
Left ventricular assist devices serve as an attractive permanent therapy option for patients with advanced heart failure who are ineligible for heart transplantation.
Ventricular assist devices offer an alternative permanent therapy for patients with advanced heart failure who are ineligible for heart transplantation.
May guide shared decision-making on destination therapy in advanced HF; leaves open need for contemporary randomized comparisons.
Traditionally, the only definitive therapy for patients who have advanced, medically refractory heart failure was replacement of the heart with another human heart. However, transplantation is an inadequate option in light of the large number of potential candidates, the lack of donors, and the coexisting conditions that make most potential candidates ineligible for transplantation. In this context, ventricular assist devices, or heart pumps, become an attractive option for patients who have advanced heart failure.Rather than replacing the human heart completely, ventricular assist devices serve in a true “assistance” capacity by supplementing the cardiac output of the native but weakened . . .
No takes yet. Share an insight, caveat, or question.
James C. Fang (2009) conducted a review in Advanced heart failure. Left Ventricular Assist Devices was evaluated. Left ventricular assist devices serve as an attractive permanent therapy option for patients with advanced heart failure who are ineligible for heart transplantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: